Brooks, Moore & Associates, Inc. Johnson & Johnson Transaction History

Brooks, Moore & Associates, Inc.

$155 Million
Q1 2024

A detailed history of Brooks, Moore & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Brooks, Moore & Associates, Inc. holds 34,572 shares of JNJ stock, worth $5.17 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares

34,572

Previous 34,559 0.04%

Holding current value

$5.17 Million

Previous $5.42 Million 0.96%

% of portfolio

3.52%

Previous 3.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $2,017 - $2,115	13 Added 0.04%	34,572 $5.47 Million
Q4 2023 Feb 15, 2024	SELL	$145.6 - $158.88 $47,756 - $52,112	-328 Reduced 0.94%	34,559 $5.42 Million
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $123,665 - $138,537	-794 Reduced 2.23%	34,887 $5.43 Million
Q2 2023 Aug 15, 2023	SELL	$154.35 - $166.11 $11,576 - $12,458	-75 Reduced 0.21%	35,681 $5.91 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $463,874 - $553,578	3,071 Added 9.4%	35,756 $5.54 Million

Q4 2022 Feb 03, 2023	BUY	$160.2 - $179.79 $39,889 - $44,767	249 Added 0.77%	32,685 $5.77 Million
Q3 2022 Nov 17, 2022	BUY	$161.33 - $179.52 $402,518 - $447,902	2,495 Added 8.33%	32,436 $5.3 Million
Q2 2022 Aug 04, 2022	SELL	$168.19 - $186.01 $32,797 - $36,271	-195 Reduced 0.65%	29,941 $5.32 Million
Q1 2022 May 03, 2022	BUY	$158.14 - $179.59 $51,395 - $58,366	325 Added 1.09%	30,136 $5.34 Million
Q4 2021 Feb 04, 2022	SELL	$155.93 - $173.01 $36,331 - $40,311	-233 Reduced 0.78%	29,811 $5.1 Million
Q3 2021 Nov 08, 2021	BUY	$161.5 - $179.47 $24,225 - $26,920	150 Added 0.5%	30,044 $4.85 Million
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $7,017 - $7,527	44 Added 0.15%	29,894 $4.93 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $96,127 - $107,061	628 Added 2.15%	29,850 $4.91 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $11,654 - $13,377	-85 Reduced 0.29%	29,222 $4.6 Million
Q3 2020 Nov 02, 2020	BUY	$140.38 - $153.83 $76,366 - $83,683	544 Added 1.89%	29,307 $4.36 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $330,397 - $398,883	-2,565 Reduced 8.19%	28,763 $4.05 Million
Q1 2020 Apr 22, 2020	SELL	$111.14 - $153.99 $55,014 - $76,225	-495 Reduced 1.56%	31,328 $4.11 Million
Q4 2019 Jan 30, 2020	SELL	$127.5 - $146.44 $15,937 - $18,305	-125 Reduced 0.39%	31,823 $4.64 Million
Q3 2019 Oct 25, 2019	BUY	$126.95 - $142.14 $97,878 - $109,589	771 Added 2.47%	31,948 $4.13 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $27,541 - $30,290	-210 Reduced 0.67%	31,177 $4.34 Million
Q4 2018 Feb 06, 2019	BUY	$122.84 - $147.84 $3.86 Million - $4.64 Million	31,387 New	31,387 $4.05 Million

Others Institutions Holding JNJ

# of Institutions

4,153

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $391B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooks, Moore & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brooks, Moore & Associates, Inc. with notifications on news.

Account

Brooks, Moore & Associates, Inc. Johnson & Johnson Transaction History